$IPXBullishMed

IperionX Shares Up 69% In Three Months: Here’s The Latest

IperionX (ASX: IPX) shares rose 6.25% to A$5.44 on Monday and are up 69% over three months, though the stock is still down 6% year-to-date. The company said it will buy Covia Solutions’ Camden mineral and mining assets for US$3m cash, adding ~2,800 acres and pre-processed stockpiles near its Titan Project. IperionX also cited a June 4 Titan DFS and up to US$47.1m DoD funding.

7/10
6/10
Med
Bullish
today/this week as the acquisition terms and DFS linkage drive fresh positioning
bullish reception with spiking volumes on the acquisition announcement

Deal expands Titan from single-asset to district-scale, potentially de-risking feedstock and shortening development via brownfield assets.

IperionX agreed to acquire Covia’s Camden mineral assets for US$3M cash, adding pre-processed stockpiles and infrastructure adjacent to Titan.

Near-term upside bias as investors price in lower-cost, faster path to production; follow-through depends on closing and survey/drilling results.

Background

The article frames IperionX’s Titan Project as “shovel-ready” after a June 4 Definitive Feasibility Study, then adds a Camden acquisition to create a district-scale play in Tennessee’s Big Sandy Critical Minerals Province.

Why it matters

The disclosed acquisition terms (cash price, acreage, pre-processed stockpiles, and transferred infrastructure) plus the stated DoD grant support are positioned as de-risking catalysts that can improve investor confidence in timelines and supply-chain relevance.

Market relevance

A concrete, low-cash M&A add-on to a recently validated DFS asset, paired with DoD funding, is likely to drive re-rating and momentum trading in IPX.

Market effects

Supports the narrative of U.S. critical-minerals supply-chain buildout via brownfield acquisitions and DoD-aligned funding.

Could attract incremental capital to Tennessee Big Sandy critical minerals plays and related industrial infrastructure suppliers.

Reinforces rare-earth/titanium supply diversification away from China, potentially affecting sentiment across critical minerals equities.

Alternative perspectives

The US$3M price may reflect unknown metallurgy/feedstock quality; stockpiles and brownfield equipment still require costly permitting, processing validation, and offtake.

Closing timing, survey/drilling outcomes for monazite/xenotime, and whether defense/aerospace offtakes materialize are the key swing factors beyond the headline deal price.

Key entities

  • IperionX

    US critical minerals developer with the Titan Project and a Virginia titanium manufacturing campus; announced Camden acquisition and references Titan DFS.

  • Covia Solutions

    Seller of the Camden mineral and mining assets to IperionX for US$3M cash.

  • Department of Defense

    Awarded up to US$47.1M via the Industrial Base Analysis and Sustainment program to support titanium supply-chain development.

Related articles

$IPXMedAI 8/10

IperionX Raises $50 Million to Expand U.S. Titanium Production - 3DPrint.com

IperionX raised about $50 million via a public offering, selling 2.275 million shares at $21.98 each, to expand U.S. titanium manufacturing. The company plans to increase capacity in Virginia, continue its Tennessee Camden Titanium Project, and fund low-carbon titanium R&D, according to the company. Cantor Fitzgerald led, with Roth Capital Partners and B. Riley Securities co-managing.

$VODMed

EasyJet, Vodafone & Picton: Markets live

Apollo Global Management raised its easyJet (EZJ) cash offer to 715p per share, valuing the airline at £5.7bn, and easyJet’s board said it is minded to recommend. The bid is 25p higher than Castlelake’s. Other updates: MJ Gleeson (GLE) expects results in line but outlook uncertain; Impax (IPX) AUM rose to £23.3bn; Vodafone (VOD) gets e& stake sold to Xavier Niel; Schroder REIT (SREI) bid for Picton (PCTN); Hays (HAS) profit guidance; Johnson Service Group (JSG) shares fall.

$IPXHighAI 10/10

IperionX Shares Dive Following Capital Raise: The Details

IperionX (ASX:IPX) shares fell 14.14% to A$3.46 after the company priced an underwritten public offering of 2.275m ADS at US$21.98 each, raising about US$50m gross. Each ADS equals 10 ordinary shares, implying 22.75m new shares and over 22m-share dilution. Proceeds fund Virginia expansion, R&D, Camden-Titan, and general purposes.

$IPXMed

IperionX Announces Pricing of Public Offering of American Depositary Shares – LiveNews.co.nz

IperionX Limited (Nasdaq:IPX; ASX:IPX) priced an underwritten public offering of 2,275,000 ADSs at $21.98 per ADS, raising about $50 million in gross proceeds, before underwriting and offering expenses. Each ADS represents 10 ordinary shares. Proceeds will fund titanium technology commercialization, Virginia campus scale-up, Tennessee Camden-Titan development, and general corporate purposes; closing is expected July 9, 2026.

$IPXMedAI 8/10

IperionX Announces Pricing of Public Offering of American Depositary Shares

IperionX Limited (Nasdaq:IPX; ASX:IPX) priced an underwritten public offering of 2,275,000 ADSs, each representing 10 ordinary shares, at $21.98 per ADS for about $50 million in gross proceeds. The offering is expected to close July 9, 2026. Proceeds will fund titanium technology commercialization, Virginia campus expansion, Tennessee Camden-Titan work, and general corporate purposes.

$IPXMedAI 8/10

AM Edition: Top 10 Politics Articles on LiveNews.co.nz for July 6, 2026 – Full Text – LiveNews.co.nz

GlobeNewswire reports IperionX Limited (NASDAQ: IPX, ASX: IPX) has completed its acquisition of the Camden critical mineral property and infrastructure in Tennessee, adjacent to its Titan project. The company cites ~70 acres of at-surface ultra-high-grade stockpiles and ~180 acres of pre-stripped Lower McNairy access, plus established utilities and rail. A 2026 techno-economic study is targeted by year-end.